Varies: Different rheumatologic conditions respond to different drugs in different people. Nsaids may be of some benefit for mild cases, but often immune-modulators are required for control (methotrexate or newer immunosuppressants like enbrel, (etanercept) humira, remicade); latter are expensive but drug companies often have programs for those without insurance. See rheumatologist.
Answered 10/26/2012
5.6k views
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question